Get startedLog in
    Picture of Exact Therapeutics AS logo

    EXTX — Exact Therapeutics AS News Story

    0.000.00%
    no flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: FDA Clears IND Application For Exact Therapeutics' Phase 2 ENACT Trial

    Picture of Exact Therapeutics AS logoExact Therapeutics AS
    16/12/2024 07:05
    Dec 16 (Reuters) - Exact Therapeutics AS  EXTX.OL :
    * FDA CLEARS IND APPLICATION FOR EXACT THERAPEUTICS' PHASE 2
ENACT
TRIAL
    * INITIAL SAFETY REVIEW EXPECTED MID-2025

Source text:  ID:nObif9Tcwa 
Further company coverage:  EXTX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

    Recent news on Exact Therapeutics AS

    See all news